Overview

Scheduled Intranasal Ketamine

Status:
Not yet recruiting

Trial end date:
2026-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this research is to determine if scheduled intranasal ketamine effects opioid requirements in adult trauma patients with moderate to severe pain in the inpatient setting.

Phase:

Early Phase 1

Details

Lead Sponsor:

Sanford Health

Treatments:

Ketamine